New Research Identifies Molecular Signatures of Menopause and Brain Aging
Scientists discover specific protein shifts during menopause that may serve as early indicators for long-term cognitive health risks.


PENN Explainer
Hear this story explained in 90 seconds.
Researchers at the University of California, Santa Barbara, and the University of California, San Francisco, have uncovered a series of molecular changes that occur during the menopause transition. This study, published in the journal Nature Medicine, highlights how menopause acts as a whole-body biological shift rather than just a reproductive event. The team identified a specific set of proteins in the blood that change as women move through pre-, peri-, and postmenopausal stages. These findings provide new insight into how midlife biological transitions may influence brain health decades later.
Emily Jacobs, a professor of psychological and brain sciences at UC Santa Barbara, noted that these molecular fingerprints allow scientists to better understand the link between midlife changes and future cognitive outcomes. The researchers used advanced proteomic technologies to analyze thousands of proteins in women participating in the Healthy Aging Study. They discovered that levels of 16 specific molecules associated with brain aging and dementia risk increased during the menopause transition. These shifts were more closely tied to the stage of menopause than to a woman's chronological age.
This suggests that the hormonal and physiological changes of menopause itself trigger these biological signatures. To confirm these results, the team analyzed data from more than 2,800 women in the UK Biobank. This secondary analysis showed that menopause is linked to molecular signs of accelerated aging across multiple organ systems. The researchers then examined data from four independent cohorts totaling nearly 12,000 older women to see how these proteins related to brain health.
They found that women with higher levels of these risk proteins were more likely to experience poorer cognitive outcomes. In the largest cohort studied, the presence of this molecular signature was associated with a modestly higher risk of developing Alzheimer's dementia over the following 16 years. Jacobs emphasized that while these proteins do not directly cause dementia, they serve as important biological markers. The team's ultimate goal is to develop a blood test that could act as an early-warning system for dementia risk.
Such a test would function similarly to how cholesterol screenings are currently used to gauge heart disease risk. By identifying these markers in midlife, clinicians could potentially offer targeted interventions to promote healthier brain aging. This research opens new avenues for understanding the complex relationship between reproductive transitions and long-term neurological health.
You've reached your free article limit
You've read 10 of 10 free articles this month. Subscribe to Planet Earth News Network for unlimited access to neutral, global journalism — plus puzzles, podcasts, and the weekly newsletter.
Already a subscriber? Sign in.
Ask the Author
Subscribers can ask the journalist a question about this story. Subscribe to ask.
Neutrality note
Auto-harvested from global news wires and presented neutrally by PENN.
to vote
Comments
No comments yet — be the first to share your thoughts.
Related stories in Health and Fitness

New Review Suggests Reducing Protein Intake May Slow Biological Aging
2026-11-16
New Research Links Consistent Daily Routines to Reduced Pain and Depression
2026-11-16
